These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 30992045)

  • 1. Broad spectrum vasopressors: a new approach to the initial management of septic shock?
    Chawla LS; Ostermann M; Forni L; Tidmarsh GF
    Crit Care; 2019 Apr; 23(1):124. PubMed ID: 30992045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II in septic shock.
    Jadhav AP; Sadaka FG
    Am J Emerg Med; 2019 Jun; 37(6):1169-1174. PubMed ID: 30935784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimodal strategy to counteract vasodilation in septic shock.
    Leone M; Einav S; Antonucci E; Depret F; Lakbar I; Martin-Loeches I; Wieruszewski PM; Myatra SN; Khanna AK
    Anaesth Crit Care Pain Med; 2023 Jun; 42(3):101193. PubMed ID: 36621622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasopressor therapy in critically ill patients with shock.
    Russell JA
    Intensive Care Med; 2019 Nov; 45(11):1503-1517. PubMed ID: 31646370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacotherapeutic options in patients with catecholamine-resistant vasodilatory shock.
    Albertson TE; Chenoweth JA; Lewis JC; Pugashetti JV; Sandrock CE; Morrissey BM
    Expert Rev Clin Pharmacol; 2022 Aug; 15(8):959-976. PubMed ID: 35920615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II in Refractory Septic Shock.
    Antonucci E; Gleeson PJ; Annoni F; Agosta S; Orlando S; Taccone FS; Velissaris D; Scolletta S
    Shock; 2017 May; 47(5):560-566. PubMed ID: 27879559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasopressor Therapy in the Intensive Care Unit.
    Russell JA; Gordon AC; Williams MD; Boyd JH; Walley KR; Kissoon N
    Semin Respir Crit Care Med; 2021 Feb; 42(1):59-77. PubMed ID: 32820475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenergic support in septic shock: a critical review.
    Póvoa P; Carneiro AH
    Hosp Pract (1995); 2010 Feb; 38(1):62-73. PubMed ID: 20469626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed vasopressor initiation is associated with increased mortality in patients with septic shock.
    Colon Hidalgo D; Patel J; Masic D; Park D; Rech MA
    J Crit Care; 2020 Feb; 55():145-148. PubMed ID: 31731173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From a pressure-guided to a perfusion-centered resuscitation strategy in septic shock: Critical literature review and illustrative case.
    Gazmuri RJ; de Gomez CA
    J Crit Care; 2020 Apr; 56():294-304. PubMed ID: 31926637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ascorbate-dependent vasopressor synthesis: a rationale for vitamin C administration in severe sepsis and septic shock?
    Carr AC; Shaw GM; Fowler AA; Natarajan R
    Crit Care; 2015 Nov; 19():418. PubMed ID: 26612352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practice Patterns in the Initiation of Secondary Vasopressors and Adjunctive Corticosteroids during Septic Shock in the United States.
    Bosch NA; Teja B; Wunsch H; Walkey AJ
    Ann Am Thorac Soc; 2021 Dec; 18(12):2049-2057. PubMed ID: 33975530
    [No Abstract]   [Full Text] [Related]  

  • 13. The initial resuscitation of septic shock.
    Cinel I; Kasapoglu US; Gul F; Dellinger RP
    J Crit Care; 2020 Jun; 57():108-117. PubMed ID: 32135409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasopressor weaning in patients with septic shock.
    Arellano DL; Hanneman SK
    Crit Care Nurs Clin North Am; 2014 Sep; 26(3):413-25. PubMed ID: 25169693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of Timing and Catecholamine Requirements on Vasopressin Responsiveness in Critically ill Patients with Septic Shock.
    Jakowenko ND; Murata J; Kopp BJ; Erstad BL
    J Intensive Care Med; 2022 Nov; 37(11):1512-1519. PubMed ID: 35195486
    [No Abstract]   [Full Text] [Related]  

  • 16. Alpha-2 agonists to reduce vasopressor requirements in septic shock?
    Pichot C; Géloën A; Ghignone M; Quintin L
    Med Hypotheses; 2010 Dec; 75(6):652-6. PubMed ID: 20817367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An updated "norepinephrine equivalent" score in intensive care as a marker of shock severity.
    Kotani Y; Di Gioia A; Landoni G; Belletti A; Khanna AK
    Crit Care; 2023 Jan; 27(1):29. PubMed ID: 36670410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic Agents for the Treatment of Vasodilatory Shock.
    Knotzer H; Poidinger B; Kleinsasser A
    Curr Pharm Des; 2019; 25(19):2133-2139. PubMed ID: 31272348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasopressors for the Treatment of Septic Shock: Systematic Review and Meta-Analysis.
    Avni T; Lador A; Lev S; Leibovici L; Paul M; Grossman A
    PLoS One; 2015; 10(8):e0129305. PubMed ID: 26237037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasopressor and Inotrope Therapy in Cardiac Critical Care.
    Jentzer JC; Hollenberg SM
    J Intensive Care Med; 2021 Aug; 36(8):843-856. PubMed ID: 32281470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.